Adherence to antihypertensive medications: A review and update

被引:6
作者
Costa F.V. [1 ]
D'Ausilio A. [2 ]
Bianchi C. [3 ]
Negrini C. [2 ]
Lopatriello S. [4 ]
机构
[1] Department of Internal Medicine, University of Bologna, Bologna
[2] PBE Consulting, Milan
[3] Department of Health Economics, Outcome, Pricing and Reimbursement, Bayer Schering Pharma-Viale Certosa
[4] PBE Consulting, Verona
关键词
Adherence to treatment; Antihypertensive drugs; Compliance to treatment; Cost of non-compliance; Treatment discontinuation;
D O I
10.2165/11530330-000000000-00000
中图分类号
学科分类号
摘要
The aim of this review was to summarize recent findings on patients adherence and persistence to antihypertensive (AHT) therapy. A literature search was performed using MEDLINE for original studies published in the English language between April 2003 and July 2008. According to selection criteria, the review included 47 papers classified into the following groups: (i) studies assessing overall behaviour towards treatment; (ii) studies differentiating among AHT classes; and (iii) studies comparing specific AHTs. It was not possible to perform a meta-analysis due to the wide variety of study designs, objectives and definitions. However, some strong messages emerged: non-adherent patients have higher blood pressure (BP) values, which lead to a higher risk of cardiovascular events; angiotensin II type 1 receptor antagonists (angiotensin receptor blockers) are the AHTs with the best patient adherence and persistence to treatment; better treatment adherence is observed in patients using fixed versus extemporaneous AHT combinations. Improving BP control is pivotal to reduce cardiovascular events, allowing for a better use of healthcare resources, and good adherence and persistence to treatment are essential for reaching this goal. © 2009 Adis Data Information BV. All rights reserved.
引用
收藏
页码:101 / 110
页数:9
相关论文
共 67 条
[11]  
Hyre A.D., Krousel-Wood M.A., Muntner P., Et al., Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting, J Clin Hypertens (Greenwich), 9, 3, pp. 179-186, (2007)
[12]  
Lehane E., McCarthy G., An examination of the intentional and unintentional aspects of medication non-adherence in patients diagnosed with hypertension, J Clin Nurs, 16, 4, pp. 698-706, (2007)
[13]  
Marquez-Contreras E., Martell-Claros N., Gil-Guillen V., Et al., Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: The EAPACUM-HTA study, J Hypertens, 24, 1, pp. 169-175, (2006)
[14]  
Schroeder K., Fahey T., Hay A.D., Et al., Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance, J Clin Epidemiol, 59, 6, pp. 650-651, (2006)
[15]  
Wetzels G., Nelemans P., Van W.B., Et al., Determinants of poor adherence in hypertensive patients: Development and validation of the 'Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire, Patient Educ Couns, 64, 1-3, pp. 151-158, (2006)
[16]  
Zeller A., Schroeder K., Peters T.J., An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment, J Clin Epidemiol, 61, 3, pp. 282-288, (2008)
[17]  
Bautista L.E., Predictors of persistence with antihypertensive therapy: Results from the NHANES, Am J Hypertens, 21, 2, pp. 183-188, (2008)
[18]  
Bramley T.J., Gerbino P.P., Nightengale B.S., Et al., Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations, J Manag Care Pharm, 12, 3, pp. 239-245, (2006)
[19]  
Fodor G.J., Kotrec M., Bacskai K., Et al., Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central- European study, J Hypertens, 23, 6, pp. 1261-1266, (2005)
[20]  
Fung V., Huang J., Brand R., Et al., Hypertension treatment in a Medicare population: Adherence and systolic blood pressure control, Clin Ther, 29, 5, pp. 972-984, (2007)